Sales decline 54.12% to Rs 3.06 crore
Net Loss of Brawn Biotech reported to Rs 0.60 crore in the quarter ended March 2021 as against net loss of Rs 0.32 crore during the previous quarter ended March 2020. Sales declined 54.12% to Rs 3.06 crore in the quarter ended March 2021 as against Rs 6.67 crore during the previous quarter ended March 2020.For the full year,net loss reported to Rs 0.55 crore in the year ended March 2021 as against net profit of Rs 0.59 crore during the previous year ended March 2020. Sales declined 29.50% to Rs 34.98 crore in the year ended March 2021 as against Rs 49.62 crore during the previous year ended March 2020.
ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales3.066.67 -54 34.9849.62 -30 OPM %-22.55-6.90 --1.721.47 - PBDT-0.40-0.37 -8 -0.330.85 PL PBT-0.41-0.38 -8 -0.360.82 PL NP-0.60-0.32 -88 -0.550.59 PL
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
